Health care stocks were mixed pre-bell Thursday, with The Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) declining by 0.4%.
Akero Therapeutics (AKRO) shares were up more than 17% after the company said it will be acquired by Novo Nordisk (NVO) in a deal valued at up to $5.20 billion in cash.
Neogen (NEOG) shares were up more than 8% after the company reported fiscal Q1 revenue that exceeded analysts' estimates.
InMode (INMD) stock was up more than 10% after the company said it expects Q3 revenue of $92.5 million to $93 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments